Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 57573 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 60186 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 95270 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 106959 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 118545 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 121436 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 124089 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 134385 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 140166 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 142883 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 183399 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 225985 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | 276657 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHINE (M-H)- | Peak area normalized | male | diabetic | no neuropathy |